BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30239366)

  • 1. Optic Pathway Gliomas in Neurofibromatosis Type 1: Imaging and Monitoring.
    Beres SJ
    Int Ophthalmol Clin; 2018; 58(4):97-112. PubMed ID: 30239366
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of visual evoked potentials and optical coherence tomography in the screening for optic pathway gliomas in patients with neurofibromatosis type I.
    Vagge A; Camicione P; Pellegrini M; Gatti G; Capris P; Severino M; Di Maita M; Panarello S; Traverso CE
    Eur J Ophthalmol; 2021 Mar; 31(2):698-703. PubMed ID: 32066268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual-evoked potentials in the assessment of optic gliomas.
    Ng YT; North KN
    Pediatr Neurol; 2001 Jan; 24(1):44-8. PubMed ID: 11182280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired and progressive myelinated retinal nerve fibers in neurofibromatosis type 1.
    Teixeira F; Fonseca AC; Pinto F
    J AAPOS; 2019 Jun; 23(3):178-179. PubMed ID: 30772473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.
    de Blank PMK; Fisher MJ; Liu GT; Gutmann DH; Listernick R; Ferner RE; Avery RA
    J Neuroophthalmol; 2017 Sep; 37 Suppl 1(Suppl 1):S23-S32. PubMed ID: 28806346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography in the diagnosis of optic pathway gliomas.
    Parrozzani R; Clementi M; Kotsafti O; Miglionico G; Trevisson E; Orlando G; Pilotto E; Midena E
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8112-8. PubMed ID: 24169000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gliomas and neurofibromatosis type 1].
    Rebolleda G
    Arch Soc Esp Oftalmol; 2006 Apr; 81(4):191. PubMed ID: 16688641
    [No Abstract]   [Full Text] [Related]  

  • 8. Myopia associated with optic nerve gliomas in neurofibromatosis type 1.
    de Alba Campomanes AG; Avery RA; Prasad S; Liu GT
    J AAPOS; 2012 Feb; 16(1):89-91. PubMed ID: 22370674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic Pathway Gliomas in Neurofibromatosis Type 1.
    Campen CJ; Gutmann DH
    J Child Neurol; 2018 Jan; 33(1):73-81. PubMed ID: 29246098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic pathway glioma with intraocular extension in a child with neurofibromatosis type-1.
    Palma-Carvajal F; González-Valdivia H; Figueroa-Vercellino JP; Saavedra-Gutiérrez C; Rovira-Zurriaga C; Prat-Bartomeu J
    J Fr Ophtalmol; 2020 May; 43(5):e179-e181. PubMed ID: 32241588
    [No Abstract]   [Full Text] [Related]  

  • 11. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
    Wolsey DH; Larson SA; Creel D; Hoffman R
    J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
    Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R
    J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 1 and McCune-Albright syndrome occurring in the same patient.
    Gonzalez-Martin J; Glover S; Dixon S; Fryer A; Carty H; Smith C; Kaye SB; Verbov J
    Br J Dermatol; 2000 Dec; 143(6):1288-91. PubMed ID: 11122036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrocephaly in neurofibromatosis type 1: a sign post for optic pathway gliomas?
    Schindera C; Wingeier K; Goeggel Simonetti B; Diepold M; Nauer CB; Fleischhauer J; Steinlin M
    Childs Nerv Syst; 2011 Dec; 27(12):2107-11. PubMed ID: 21822956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
    Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic Pathway Gliomas Secondary to Neurofibromatosis Type 1.
    Beres SJ; Avery RA
    Semin Pediatr Neurol; 2017 May; 24(2):92-99. PubMed ID: 28941532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrocephaly Is Not a Predictor of Optic Pathway Glioma Development or Treatment in Neurofibromatosis Type 1.
    Morris SM; Monroe CL; Gutmann DH
    J Child Neurol; 2016 Dec; 31(14):1540-1545. PubMed ID: 27581847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children.
    Van Mierlo C; Spileers W; Legius E; Casteels I; Cassiman C
    Doc Ophthalmol; 2013 Dec; 127(3):177-90. PubMed ID: 23884797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teaching neuroimages: optic nerve glioma with perineural arachnoid gliomatosis in a patient with neurofibromatosis-1.
    Srinivasan K; Thomas B
    Neurology; 2015 Mar; 84(13):e97. PubMed ID: 25825471
    [No Abstract]   [Full Text] [Related]  

  • 20. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.